Use of Methylene Blue for Catecholamine-Refractory Vasoplegia from Protamine and Aprotinin

被引:38
|
作者
Del Duca, Danny
Sheth, Shashank S.
Clarke, Ann E.
Lachapelle, Kevin J.
Ergina, Patrick L.
机构
[1] McGill Univ, Div Cardiovasc Surg, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Div Allergy, Ctr Hlth, Montreal, PQ, Canada
[3] McGill Univ, Div Clin Immunol, Ctr Hlth, Montreal, PQ, Canada
来源
ANNALS OF THORACIC SURGERY | 2009年 / 87卷 / 02期
关键词
CARDIAC-SURGERY; SHOCK;
D O I
10.1016/j.athoracsur.2008.07.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present two cases of catecholamine-refractory and vasopressin-refractory vasoplegic syndrome associated with intraoperative anaphylaxis during cardiac surgery. One case was related to the administration of protamine and the other case to the administration of aprotinin. Both cases were successfully managed using intravenous methylene blue. The use of methylene blue blocks accumulation of cyclic guanosine monophosphate by competitively inhibiting the enzyme guanylate cyclase. This results in reduced responsiveness of the vasculature to cyclic guanosine monophosphate-mediated vasodilators, such as nitric oxide. This report provides a description of severe anaphylaxis induced by different agents, in which the use of methylene blue was associated with a significant clinical response.
引用
收藏
页码:640 / 642
页数:4
相关论文
共 50 条
  • [21] Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
    Peyko, Vincent
    Finamore, Michael
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [22] Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review
    Pluta, Michal P.
    Putowski, Zbigniew
    Czempik, Piotr F. F.
    Krzych, Lukasz J.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [23] The Use of Methylene Blue in Conjunction With Hydroxocobalamin and Multiple Pressors to Treat Severe Vasoplegia in a Patient Due to Calcium Channel Blocker Toxicity: A Case Report
    Hacker, Aaron
    Irvine, Dylan S.
    Gross, Michael
    Thornton, Imani
    Marin, Diego
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [24] Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation
    Pai, Sher-Lu
    Torp, Klaus D.
    Insignares, Vianca C.
    DeMaria Jr, Samuel
    Giordano, Chris R.
    Logvinov, Ilana I.
    Li, Zhuo
    Chadha, Ryan
    Aniskevich III, Stephen
    [J]. CLINICAL TRANSPLANTATION, 2024, 38 (03)
  • [25] Post-Mortem Analysis of Methylene Blue Distribution Following Its Use as Treatment for Refractory Shock
    Lowder, Lindsey
    Zhang, Wujuan
    Sharma, Diyya
    Skelton, Melita
    Angel, Rita
    Setchell, Kenneth
    Smith, Roger
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 7A - 7A
  • [26] Post-Mortem Analysis of Methylene Blue Distribution Following Its Use as Treatment for Refractory Shock
    Lowder, Lindsey
    Zhang, Wujuan
    Sharma, Divya
    Skelton, Melita
    Angel, Rita
    Setchell, Kenneth
    Smith, Roger
    [J]. MODERN PATHOLOGY, 2015, 28 : 7A - 7A
  • [27] Use of papaya seeds as a biosorbent of methylene blue from aqueous solution
    Paz, Diego S.
    Baiotto, Alexandre
    Schwaab, Marcio
    Mazutti, Marcio A.
    Bassaco, Mariana M.
    Bertuol, Daniel A.
    Foletto, Edson L.
    Meili, Lucas
    [J]. WATER SCIENCE AND TECHNOLOGY, 2013, 68 (02) : 441 - 447
  • [28] Use of Combitube airway to protect the airway from methylene blue dye
    MH Mercer
    [J]. Critical Care, 4 (Suppl 1):
  • [29] Use of Aspergillus wentii for biosorption of methylene blue from aqueous solution
    Acemioglu, Bilal
    Kertmen, Metin
    Digrak, Metin
    Alma, M. Hakki
    [J]. AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (06): : 874 - 881
  • [30] Methylene blue used in the treatment of refractory vasoplegic shock resulting from severe quetiapine poisoning
    Fisher, Julia
    Taori, Gopal
    Graudins, Andis
    Braitberg, George
    [J]. CLINICAL TOXICOLOGY, 2013, 51 (04) : 368 - 368